Loss of Physical Performance, Strength, and Muscle in Sarcopenia
Received Date: Jul 02, 2022 / Accepted Date: Jul 29, 2022 / Published Date: Jul 30, 2022
Abstract
A characteristic of ageing, sarcopenia is described as the loss of muscular mass, strength, and physical performance. It is usually linked to altered amino acid metabolism, increased muscle protein catabolism in comparison to anabolism, and muscle fiber loss. Sarcopenia can coexist with obesity [sarcopenic obesity (SO)], or it might be linked to a general decrease of body mass. Sarcopenia has been demonstrated to contribute to poor surgical results,increased chemotherapy toxicity associated with both cytotoxic and targeted drugs, as well as negatively affecting survival in patients with malignant illness; however its effects may even be more severe in these individuals. While sarcopenia development is a common age-related phenomenon, the catabolic processes that go along with it seem to be encouraged by physical inactivity, poor nutrition, and systemic low-grade inflammation, in addition to intrinsic muscle and molecular changes, such as mitochondrial dysfunction and impaired muscle stem cell regenerative capacity.Although many older cancer patients do not meet the recommendations for physical activity and nutrition, and cancer treatment can make it more challenging to make positive lifestyle changes, increased physical activity and an adequate protein intake can reduce the incidence and severity of sarcopenia in cancer patients. The detrimental clinical effects of sarcopenia in older people, particularly older cancer patients, are explored. Along with recommendations for therapies,reviews of lifestyle, molecular, and cellular variables that affect sarcopenia and its concomitant consequences are also included.
Citation: Cavero I (2022) Loss of Physical Performance, Strength, and Muscle in Sarcopenia. J Nov Physiother 12: 531. Doi: 10.4172/2165-7025.1000531
Copyright: © 2022 Cavero I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1125
- [From(publication date): 0-2022 - Aug 17, 2024]
- Breakdown by view type
- HTML page views: 952
- PDF downloads: 173